http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106692136-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecf7b4c1766eed71010670e4da94a5b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
filingDate 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45cc01649792ecd38729c4e36974f554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5717583614e955b92d6c9d16f7af9c53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f70cb332baa919344e02c0a9532981d
publicationDate 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106692136-A
titleOfInvention Application of the composition of Harrisotone A derivatives in anti-acute gout medicine
abstract The invention discloses the application of the composition of Harrisotone A derivatives in anti-acute gout medicine, that is, O-(tetrahydropyrrolyl) ethyl derivatives and O-(dihydroxyethylamino) ethyl derivatives of Harrisotone A The application of the composition of the compound in the anti-acute gout drug, the invention relates to the fields of organic synthesis and medicinal chemistry, in particular to the composition, preparation method and application of the Harrisotone A derivative in the preparation of the anti-acute gout drug. The invention discloses a composition of Harrisotone A derivatives and a preparation method thereof. Pharmacological experiments show that the Harrisotone A derivative composition of the present invention has anti-acute gout effect, and has the value of developing anti-acute gout drugs.
priorityDate 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101646440-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467814158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421327042

Total number of triples: 28.